Synchron, Inc.
Clinical trials sponsored by Synchron, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Mind-Controlled tech trial launches for ALS patients Results expected Dec 2026 (estimated)
- Mind-Controlled tech: brain implant trial aims to restore independence for paralysis patients Results expected Mar 2027 (estimated)
- Mind-Controlled tech trial launches for ALS patients Results expected Jun 2027 (estimated)
-
Mind-Controlled tech: brain implant trial aims to restore independence for paralysis patients
Disease control Recruiting nowThis study tests a brain-computer implant (Stentrode) for people with paralysis from motor neuron disease or similar conditions. The device is placed in a blood vessel near the brain and aims to let users control computers or assistive devices with thought. The trial focuses on s…
Sponsor: Synchron, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Mind-Controlled tech trial launches for ALS patients
Disease control Recruiting nowThis early study tests a brain-computer implant placed through blood vessels to help people with ALS control external devices using their thoughts. Ten participants with ALS and arm weakness will be followed for safety and device function. The goal is to restore some independence…
Sponsor: Synchron, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Mind-Controlled tech trial launches for ALS patients
Disease control Recruiting nowThis study tests a brain-computer implant (BCI) that lets people with ALS or motor neuron disease control digital devices using only their thoughts. Ten participants will receive the implant, and researchers will monitor safety and how well the device works over one year. The goa…
Sponsor: Synchron, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC